Saxenda Compared to Ozempic - How These Weight Loss Drugs Differ

Saxenda Compared to Ozempic - How These Weight Loss Drugs Differ
Table Of Content
Close

Saxenda vs. Ozempic: How These Weight Loss Drugs Compare

With obesity rates continuing to rise, the demand for effective weight loss solutions has led to the development of several prescription medications. Saxenda and Ozempic are two popular options for long-term weight management. But what's the difference between the two?

What is Saxenda?

Saxenda is a weight loss medication injected under the skin once daily. The generic name is liraglutide. It was originally approved in 2014 for chronic weight management in adults with obesity or who are overweight with an obesity-related condition like type 2 diabetes.

Saxenda works by mimicking the hormone GLP-1, which helps control appetite and food intake. It activates areas of the brain involved in appetite regulation, increasing feelings of fullness and satisfaction after eating. This allows you to feel satisfied with smaller portions of food.

How Saxenda Helps with Weight Loss

Saxenda promotes weight loss through the following mechanisms:

  • Suppresses appetite
  • Prevents overeating by increasing satiety
  • Slows digestion to stabilize blood sugar
  • Discourages cravings and snacking behaviors

By reducing hunger and calorie intake, Saxenda enables moderate but sustainable weight loss. Users typically lose 5-10% of their body weight over 3-6 months.

Who is Saxenda For?

Saxenda is intended for certain adults who are obese or have overweight related health issues. Candidates include:

  • Adults with a BMI over 30 (classified as obese)
  • Overweight adults with a BMI of 27 or higher plus an obesity-related condition like hypertension, high cholesterol, or type 2 diabetes

Saxenda should be used along with a reduced calorie meal plan and increased physical activity. It is not recommended for those with a personal or family history of certain cancer types.

Potential Saxenda Side Effects

When used as prescribed, Saxenda is generally well tolerated. However, some possible side effects may include:

  • Nausea, vomiting, diarrhea - especially when first starting
  • Hypoglycemia in patients with diabetes - monitor blood sugar
  • Gallstones
  • Pancreatitis
  • Increased heart rate

Rare but serious risks include thyroid tumors and kidney impairment. Contact your doctor if any severe side effects develop.

What is Ozempic?

Ozempic is another type of injectable weight loss medication. The generic drug is semaglutide. It was originally FDA approved in 2017 for controlling blood sugar in type 2 diabetes. In 2021, a higher dose of Ozempic called Wegovy was approved specifically for chronic weight management.

Like Saxenda, Ozempic works by mimicking the hormone GLP-1 to stimulate satiety. It helps glucose dependent insulin secretion from the pancreas to manage blood sugar levels.

How Ozempic Aids Weight Loss

Ozempic promotes weight loss by:

  • Slowing digestion to increase feelings of fullness
  • Suppressing appetite between meals
  • Reducing cravings and impulsive eating
  • Balancing blood sugar to prevent energy crashes and spikes

This dual action of glucose control and appetite suppression enables gradual but significant fat loss. Clinical trials showed average weight loss of 15% over 68 weeks.

Who Should Use Ozempic?

The semaglutide in Ozempic is approved for the following uses:

  • Lower blood sugar in adults with type 2 diabetes - 1mg dose
  • Chronic weight management in obese or overweight adults - 2.4mg dose (Wegovy)

Ozempic should be prescribed by a doctor along with lifestyle changes like diet and exercise. It has not been studied sufficiently in patients under 18 years old.

Potential Ozempic Side Effects

Ozempic may cause certain side effects including:

  • Nausea, vomiting, diarrhea - often improves over time
  • Hypoglycemia - monitor blood glucose levels
  • Constipation
  • Stomach pain, indigestion
  • Gallstones
  • Kidney problems

Rarely, semaglutide may increase risk of thyroid cancer. Report any persistent or severe side effects to your healthcare provider.

Comparing Saxenda vs. Ozempic

Since both Saxenda and Ozempic utilize GLP-1 receptor agonists, they work via similar mechanisms. But there are some key differences between the two medications:

Active Ingredients

The active ingredients differ between Saxenda and Ozempic/Wegovy:

  • Saxenda - Liraglutide 3mg
  • Ozempic - Semaglutide 1mg or 2.4mg (Wegovy)

While chemically related, liraglutide and semaglutide are distinct medications requiring separate prescriptions.

Approved Uses

Indications for the two drugs vary slightly:

  • Saxenda - Weight management only
  • Ozempic - Type 2 diabetes and weight loss (Wegovy)

Saxenda is specifically FDA approved for chronic weight management. Ozempic is also used for blood sugar control in diabetes.

Dosing Frequency

How often the drugs are dosed differs:

  • Saxenda - Daily injection
  • Ozempic - Weekly injection

Saxenda must be injected subcutaneously once per day. Ozempic is dosed just once weekly, which may increase compliance.

Weight Loss Efficacy

Weight loss results are slightly better with semaglutide:

  • Saxenda - 5-10% weight loss over 3-6 months
  • Ozempic - 15% weight loss over 68 weeks

Both medications are effective for weight loss, but Ozempic/Wegovy tend to produce greater fat reduction over time.

Side Effects

The medications have comparable safety profiles overall. Common side effects for both include:

  • GI issues like nausea, vomiting, diarrhea
  • Hypoglycemia
  • Headaches
  • Indigestion
  • Decreased appetite

Rare risks include medullary thyroid tumors, kidney disease, pancreatitis, and gallstones. The types and frequencies of side effects are fairly similar.

Who Should Choose Saxenda vs. Ozempic?

When determining if Saxenda or Ozempic is more appropriate, the doctor will consider:

  • Presence of diabetes - Ozempic treats diabetes along with obesity
  • Weight loss goals - Ozempic may produce greater weight loss
  • Need for blood sugar control - Ozempic lowers blood glucose
  • Frequency of dosing - Saxenda daily or Ozempic weekly
  • Side effect tolerance - Similar for both medications
  • Cost and insurance coverage - Varies by plan

Have an in-depth discussion with your healthcare provider about your individual needs and circumstances to decide if Saxenda or Ozempic better fits your lifestyle and health goals.

The Bottom Line

Saxenda and Ozempic are two highly effective medications for managing obesity over the long-term. Both GLP-1 receptor agonists act in the brain to increase feelings of fullness and satisfaction from smaller food portions. This enables gradual but meaningful fat loss along with lifestyle interventions. While the drugs have slightly different indications, dosing frequencies, and efficacy, they both safely produce significant weight loss results when used appropriately under medical supervision.

FAQs

How do Saxenda and Ozempic promote weight loss?

Both Saxenda and Ozempic suppress appetite, increase feelings of fullness, reduce food cravings, and slow digestion to promote weight loss.

What are the side effects of Saxenda and Ozempic?

Common side effects for both medications include nausea, vomiting, diarrhea, hypoglycemia, headaches, and decreased appetite. Rare risks include thyroid tumors, pancreatitis, and kidney problems.

How often are Saxenda and Ozempic dosed?

Saxenda is injected once daily while Ozempic is injected once weekly.

Which causes more weight loss, Saxenda or Ozempic?

Ozempic generally produces greater weight loss over time, with users losing 15% of their body weight on average.

Who are Saxenda and Ozempic approved for?

Both drugs are approved for obese adults or those who are overweight with an obesity-related condition. Ozempic also treats type 2 diabetes.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new treatment regimen.

Add Comment

Click here to post a comment

Related Coverage

Latest news